Search Results
Clinical Implications of Bezlotoxumab for Recurring C Diff Infections
Bezlotoxumab for Prevention of Clostridium difficile Infection Recurrence
Bezlotoxumab More Effective in Patients with High Risk for C Diff Recurrence
Bezlotoxumab for Prevention of Recurrent C. Difficile Infection
Clostridium Difficile: The Role of Bezlotoxumab
Clostridium Difficile: The Role of Bezlotoxumab
Factors That Impact Clostridium Difficile Infection Recurrence
The Clinical Significance of Clostridium Difficile Infections
Case-Based Discussion: Treatment Considerations for IBD Patients With Recurrent C. diff Infections
Clinical Approaches to the Effective Treatment of C. diff as an Infectious Disease
Clostridium Difficile Treatment: Focus on the New Guidelines -- Amanda Mercurio, PharmD.
Zinplava (bezlotoxumab)- recurrence of Clostridium difficile infection (CDI)
